Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05143476 · ClinicalTrials.gov registry record
Serum-Protein-Based Indices for the Progression of Fracture Healing and Nonunion
A clinical trial of Humerus Fractures, sponsored by Major Extremity Trauma Research Consortium.
- Completed
- Registry status
- 45
- Enrollment target
- 1
- Study location
NCT05143476 is a study of Humerus Fractures that has completed, run by Major Extremity Trauma Research Consortium. The registered enrollment target is 45 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05143476, a study of Humerus Fractures, has completed, sponsored by Major Extremity Trauma Research Consortium.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
To define a serum protein-based diagnostic for the progression and failure of fracture healing, through the identification of a set of serum proteins that appear at early times of biological healing and show a specific correlation with later radiological and functional signs used to define delayed healing and non-union.
Conditions Studied
Study Locations (1)
Massachusetts
- Boston Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2021-06-26 |
| Est. Completion | 2024-10-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05143476
The ClinicalTrials.gov registry entry for NCT05143476 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Major Extremity Trauma Research Consortium, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Humerus Fractures appearing as the primary indexed condition, and to 0 interventions.
NCT05143476 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05143476 about?
NCT05143476 is a clinical study titled "Serum-Protein-Based Indices for the Progression of Fracture Healing and Nonunion". To define a serum protein-based diagnostic for the progression and failure of fracture healing, through the identification of a set of serum proteins that appear at early times of biological healing and show a specific correlation with later radiological and functional signs used to define delayed h...
What is the current status of trial NCT05143476?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2021-06-26. Estimated completion is 2024-10-28.
What conditions does trial NCT05143476 study?
This clinical trial studies the following conditions: Humerus Fractures.
Who is sponsoring clinical trial NCT05143476?
This trial is sponsored by Major Extremity Trauma Research Consortium, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05143476 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Humerus Fractures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.